December 2, 2025 02:42 PM EST
FDA+
FDA to remove some monkey testing from monoclonal antibody development
Zachary Brennan
Senior Editor
The FDA on Tuesday unveiled new recommendations on how biopharma companies can in some cases reduce or eliminate testing monoclonal antibodies (mAbs) in monkeys before …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS
Client Engagement Mgr - Life Sciences Strategy & Intelligence
Sedulo Group
Remote
VIEW JOB OFFER
post your job now